Scheetz, Jane
Rothschild, Philip
McGuinness, Myra
Hadoux, Xavier
Soyer, H. Peter
Janda, Monika
Condon, James J.J.
Oakden-Rayner, Luke
Palmer, Lyle J.
Keel, Stuart
van Wijngaarden, Peter
Article History
Received: 18 October 2020
Accepted: 12 February 2021
First Online: 4 March 2021
Competing interests
: The authors declare the following competing interests: HPS is a shareholder of MoleMap NZ Limited and e-derm consult GmbH and undertakes regular teledermatological reporting for both companies. HPS is a Medical Consultant for Canfield Scientific Inc., MetaOptima and Revenio Research Oy and also a Medical Advisor for First Derm. HPS holds an NHMRC MRFF Next Generation Clinical Researchers Program Practitioner Fellowship (APP1137127). The authors declare that there are no other competing interests. The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian Government.